levacetylleucine

FDA Drug Profile — AQNEURSA

Drug Details

Generic Name
levacetylleucine
Brand Names
AQNEURSA
Application Number
NDA219132
Sponsor
Patheon France S.A.S
NDC Codes
2
Dosage Forms
GRANULE, FOR SUSPENSION
Routes
ORAL
Active Ingredients
LEVACETYLLEUCINE

Indications and Usage

1 INDICATIONS AND USAGE AQNEURSA™ is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg. AQNEURSA is indicated for the treatment of neurological manifestations of Niemann-Pick disease type C (NPC) in adults and pediatric patients weighing ≥15 kg. ( 1 )